Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Protein misfolding and the formation of aggregates are increasingly recognized components of the pathology of human genetic disease and hallmarks of many neurodegenerative disorders. As exemplified by polyglutamine diseases, the propensity for protein misfolding is associated with the length of polyglutamine expansions and age-dependent changes in protein-folding homeostasis, suggesting a critical role for a protein homeostatic buffer. To identify the complement of protein factors that protects cells against the formation of protein aggregates, we tested transgenic Caenorhabditis elegans strains expressing polyglutamine expansion yellow fluorescent protein fusion proteins at the threshold length associated with the age-dependent appearance of protein aggregation. We used genome-wide RNA interference to identify genes that, when suppressed, resulted in the premature appearance of protein aggregates. Our screen identified 186 genes corresponding to five principal classes of polyglutamine regulators: genes involved in RNA metabolism, protein synthesis, protein folding, and protein degradation; and those involved in protein trafficking. We propose that each of these classes represents a molecular machine collectively comprising the protein homeostatic buffer that responds to the expression of damaged proteins to prevent their misfolding and aggregation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Impaired intracellular transport, a hallmark of HD, is closely linked to PC dysfunction, which can alter ciliary structure and disrupt the trafficking of signaling molecules regulating Shh and Wnt pathways [54,171,172].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [171]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Impaired intracellular transport, a hallmark of HD, is closely linked to PC dysfunction, which can alter ciliary structure and disrupt the trafficking of signaling molecules regulating Shh and Wnt pathways [54,171,172].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [171]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
TRiC/CCT cooperates with different upstream chaperones in the folding of distinct protein classes
Siegers, K., Bölter, B., Schwarz, J. P., Böttcher, U. M. K., Guha, S., & Hartl, F. U. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg483 · Cited by 118
RetractedSystematic functional analysis of the Caenorhabditis elegans genome using RNAi
Kamath, R. S., Fraser, A. G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., et al. (2003) · Nature · doi:10.1038/nature01278 · Cited by 3,616
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Quality control in the endoplasmic reticulum
Ellgaard, L., & Helenius, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1052 · Cited by 2,126
Timmons, L., Court, D. L., & Fire, A. (2001) · Gene · doi:10.1016/s0378-1119(00)00579-5 · Cited by 1,843
Regulation of aging and age-related disease by DAF-16 and heat-shock factor
Hsu, A.-L., Murphy, C. T., & Kenyon, C. (2003) · Science · doi:10.1126/science.1083701 · Cited by 1,513
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291
Toxic Proteins in Neurodegenerative Disease
Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002) · Science · doi:10.1126/science.1067122 · Cited by 1,251
Cited by
Finding function in novel targets: C. elegans as a model organism
Kaletta, T., & Hengartner, M. O. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2031 · Cited by 1,093
Yoshida, H. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05639.x · Cited by 1,086
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024
“elegans , two members of the HSP70 family and one DnaJ domain protein (an HSP40 homologue) were identified as suppressors of aggregatio”
Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways
Schulman, B. A., & Wade Harper, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2673 · Cited by 943
“elegans leads to enhanced aggregation of a polyglutamine-containing protein, which is consistent with the involvement of the ubiquitin system in removing misfolded and polyglutamine-containing protein”
Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging
Morimoto, R. I. (2008) · Genes & Development · doi:10.1101/gad.1657108 · Cited by 872
Self-citationRegulation of H SF 1 Function in the Heat Stress Response: Implications in Aging and Disease
Anckar, J., & Sistonen, L. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060809-095203 · Cited by 773
Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging
Ben-Zvi, A., Miller, E. A., & Morimoto, R. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902882106 · Cited by 649
Self-citationProgressive disruption of cellular protein folding in models of polyglutamine diseases
Gidalevitz, T., Ben-Zvi, A., Ho, K. H., Brignull, H. R., & Morimoto, R. I. (2006) · Science · doi:10.1126/science.1124514 · Cited by 643
Self-citationWidespread protein aggregation as an inherent part of aging in C. elegans
David, D. C., Ollikainen, N., Trinidad, J. C., Cary, M. P., Burlingame, A. L., & Kenyon, C. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000450 · Cited by 627
“Found at: doi:10.1371/journal.pbio.1000450.s015 (0.03 MB XLS) Table S8 Proteins identified as aggregation-prone and identified in RNAi screens for increased polyglutamine aggregation (Nollen et al., 2004 [20]).”
InfluentialA chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease
Brehme, M., Voisine, C., Rolland, T., Wachi, S., Soper, J. H., Zhu, Y., Orton, K., Villella, A., Garza, D., Vidal, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.042 · Cited by 584
“Previous studies using RNAi in C. elegans have identified components acting in protein degradation as modifiers of polyQ proteotoxicity (Nollen et al., 2004).”
Self-citationAging as an event of proteostasis collapse
Taylor, R. C., & Dillin, A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004440 · Cited by 538
“…highly protective against polyQ aggregation, and that many other components of the proteostasis network are modulators of polyQ toxicity, including genes involved in RNA metabolism and protein synthesis, folding, trafficking, and degradation (Hsu et al. 2003; Nollen et al. 2004; Jia et al. 2007).”
Cellular Strategies of Protein Quality Control
Chen, B., Retzlaff, M., Roos, T., & Frydman, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004374 · Cited by 502
“, polyQ, Ab, a-synuclein, SOD1) (Fonte et al. 2002; Nollen et al. 2004; van Ham et al. 2008; Roodveldt et al. 2009).”
Landles, C., & Bates, G. P. (2004) · EMBO reports · doi:10.1038/sj.embor.7400250 · Cited by 488
“By RNA interference in various worm strains, Nollen and colleagues identified only two Hsp70s and one member of the DnaJ family of proteins that affected aggregation among all the chaperone genes analysed (Nollen et al, 2004).”
Converging pathways in neurodegeneration, from genetics to mechanisms
Gan, L., Cookson, M. R., Petrucelli, L., & La Spada, A. R. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0237-7 · Cited by 479
C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging
van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M. W., Plasterk, R. H. A., & Nollen, E. A. A. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000027 · Cited by 427
“RNAi Screen Synchronized larvae were grown in liquid culture in 96-well plates, on bacterial strains from the Ahringer bacterial RNAi library as described [6,32].”
InfluentialSelf-citationCelastrols as Inducers of the Heat Shock Response and Cytoprotection
Westerheide, S. D., Bosman, J. D., Mbadugha, B. N. A., Kawahara, T. L. A., Matsumoto, G., Kim, S., Gu, W., Devlin, J. P., Silverman, R. B., & Morimoto, R. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409267200 · Cited by 427
Self-citationThe Heat Shock Response: Systems Biology of Proteotoxic Stress in Aging and Disease
Morimoto, R. I. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010637 · Cited by 407
“Genome-wide RNAi screens of C. elegans expressing Q35-YFP have identified approximately 340 genetic modifiers that either enhance or inhibit the PN and thus increase or decrease polyQ aggregation (Nollen et al. 2004; Silva et al. 2011).”
Self-citationHuntington's disease: from pathology and genetics to potential therapies
Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C.-W., Saiki, S., Rose, C., Krishna, G., Davies, J. E., Ttofi, E., Underwood, B. R., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071619 · Cited by 409
Protein aggregates in Huntington's disease
Arrasate, M., & Finkbeiner, S. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.12.013 · Cited by 383
“The chaperonin TRiC was identified as a modulator of aggregation in a genome-wide RNA interference screen in Caenorhabditis elegans (Nollen et al., 2004).”
Protein homeostasis and aging in neurodegeneration
Douglas, P. M., & Dillin, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201005144 · Cited by 372
“However, manipulating the aging process through key metabolic signaling molecules can hamper age-mediated proteostasis suppressor of polyglutamine toxicity, the TriC chaperonin complex (Nollen et al., 2004), remodeled 200-kD proteotoxic oligomers into benign 500-kD aggregates in a yeast model (Behrends et al.”
Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets
Spiess, C., Meyer, A. S., Reissmann, S., & Frydman, J. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.09.015 · Cited by 377
“Experiments in Caenorhabditis elegans show that decreasing the concentration of TRiC subunits by RNA interference enhances the formation of polyglutamine aggregates, such as those found in Huntington’s disease [49].”
Protein Quality Control by Molecular Chaperones in Neurodegeneration
Ciechanover, A., & Kwon, Y. T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00185 · Cited by 346
Polyglutamine neurodegeneration: protein misfolding revisited
Williams, A. J., & Paulson, H. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.004 · Cited by 341
Tam, S., Geller, R., Spiess, C., & Frydman, J. (2006) · Nature Cell Biology · doi:10.1038/ncb1477 · Cited by 309
“Recently, a genome-wide RNAi screen in Caenorhabditis elegans searching for endogenous regulators of polyQ aggregation isolated, in addition to Hsp70 and Hsp40, six of the eight subunits of the eukaryotic chaperonin TRi”
Network Organization of the Huntingtin Proteomic Interactome in Mammalian Brain
Shirasaki, D. I., Greiner, E. R., Al-Ramahi, I., Gray, M., Boontheung, P., Geschwind, D. H., Botas, J., Coppola, G., Horvath, S., Loo, J. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.024 · Cited by 297
“, 2007) Rplp0 worm: (Nollen et al., 2004) Nsf worm: (Nollen et al.”
InfluentialCytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state
Kitamura, A., Kubota, H., Pack, C.-G., Matsumoto, G., Hirayama, S., Takahashi, Y., Kimura, H., Kinjo, M., Morimoto, R. I., & Nagata, K. (2006) · Nature Cell Biology · doi:10.1038/ncb1478 · Cited by 278
Self-citationChaperonin TRiC Promotes the Assembly of polyQ Expansion Proteins into Nontoxic Oligomers
Behrends, C., Langer, C. A., Boteva, R., Böttcher, U. M., Stemp, M. J., Schaffar, G., Rao, B. V., Giese, A., Kretzschmar, H., Siegers, K., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.017 · Cited by 278
“To determine whether the proposed involvement of TRiC in polyQ aggregation (Nollen et al., 2004) is direct, we performed in vitro experiments with bovine TRiC and a purified exon 1 fragment of Htt containing a pathologically expanded polyQ repeat of 53 Q. Similar N-terminal fragments, generated by…”
InfluentialFinkbeiner, S. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007476 · Cited by 255
“Similarly, a screen was performed for genes whose suppression led to the premature appearance of inclusion bodies by a polyQ containing polypetide in Caenorhabditis elegans (Nollen et al. 2004).”
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model
Hamamichi, S., Rivas, R. N., Knight, A. L., Cao, S., Caldwell, K. A., & Caldwell, G. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711018105 · Cited by 268
“elegans and yeast have implicated various classes of gene products that influence the misfolding or clearance of polyglutamine repeat-containing proteins (15, 22).”
Shaping proteostasis at the cellular, tissue, and organismal level
Sala, A. J., Bott, L. C., & Morimoto, R. I. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201612111 · Cited by 247
“Genome-wide screens for modifiers of polyglutamine aggregation and toxicity have identified genes that are highly enriched in PN components, with molecular chaperones being an important class (Nollen et al., 2004; Bilen and Bonini, 2007; Silva et al., 2011).”
Self-citationHsp70 and Its Molecular Role in Nervous System Diseases
Turturici, G., Sconzo, G., & Geraci, F. (2011) · Biochemistry Research International · doi:10.1155/2011/618127 · Cited by 246
CHIP Suppresses Polyglutamine Aggregation and Toxicity In Vitro and In Vivo
Miller, V. M., Nelson, R. F., Gouvion, C. M., Williams, A., Rodriguez-Lebron, E., Harper, S. Q., Davidson, B. L., Rebagliati, M. R., & Paulson, H. L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3001-05.2005 · Cited by 236
Firefly luciferase mutants as sensors of proteome stress
Gupta, R., Kasturi, P., Bracher, A., Loew, C., Zheng, M., Villella, A., Garza, D., Hartl, F. U., & Raychaudhuri, S. (2011) · Nature Methods · doi:10.1038/nmeth.1697 · Cited by 219
Wang, J., Farr, G. W., Hall, D. H., Li, F., Furtak, K., Dreier, L., & Horwich, A. L. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000350 · Cited by 206
Genome‐wide screening for gene function using RNAi in mammalian cells
Cullen, L. M., & Arndt, G. M. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01332.x · Cited by 214
Regulation of Organismal Proteostasis by Transcellular Chaperone Signaling
van Oosten-Hawle, P., Porter, R. S., & Morimoto, R. I. (2013) · Cell · doi:10.1016/j.cell.2013.05.015 · Cited by 198
“Ahringer, University of Cambridge, Cambridge, UK) as described previously (Nollen et al., 2004).”
Self-citationProtein interactions and disease: computational approaches to uncover the etiology of diseases
Kann, M. G. (2007) · Briefings in Bioinformatics · doi:10.1093/bib/bbm031 · Cited by 201
“For instance, several aspects of the polyQ diseases (see previous section) were modeled using worm, fly and yeast [128–131].”
The molecular genetics of Huntington disease — a history
Bates, G. P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1686 · Cited by 193
Fujikake, N., Nagai, Y., Popiel, H. A., Okamoto, Y., Yamaguchi, M., & Toda, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710521200 · Cited by 199
Small-molecule proteostasis regulators for protein conformational diseases
Calamini, B., Silva, M. C., Madoux, F., Hutt, D. M., Khanna, S., Chalfant, M. A., Saldanha, S. A., Hodder, P., Tait, B. D., Garza, D., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.763 · Cited by 199
Self-citationGenome-Wide Screen for Modifiers of Ataxin-3 Neurodegeneration in Drosophila
Bilen, J., & Bonini, N. M. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030177 · Cited by 196
“elegans screen revealed a large number of modifiers of a pure polyQ aggregation phenotype [20].”
Gidalevitz, T., Krupinski, T., Garcia, S., & Morimoto, R. I. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000399 · Cited by 192
“elegans have been used to investigate the aggregation toxicity and genetic modifiers of polyglutamine expansions and a-synuclein [25–27].”
Self-citationProtein Homeostasis in Models of Aging and Age-Related Conformational Disease
Kikis, E. A., Gidalevitz, T., & Morimoto, R. I. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-7002-2_11 · Cited by 185
“Adapted from Nollen et al, 2004 Eyes (i-iv) and retinal sections (v,vi) of flies expressing expanded polyglutamine protein and human HSPA1L are shown. i,v, Control fly expressing only the promoter transgene. ii,vi, Flies expressing HSPA1L, coding for Hsp70 protein.”
Self-citationAge‐dependent changes and biomarkers of aging in Caenorhabditis elegans
Son, H. G., Altintas, O., Kim, E. J. E., Kwon, S., & Lee, S. V. (2019) · Aging Cell · doi:10.1111/acel.12853 · Cited by 183
“Age‐dependent increases in neuronal abnormalities, including neurite branching and irregularly shaped soma in mechanosensory neurons, are delayed in daf‐2 mutants compared to the wild type (Pan et al., 2011; Tank et al., 2011).”
Lamitina, T., Huang, C. G., & Strange, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602987103 · Cited by 183
Protein misfolding and disease: from the test tube to the organism
Luheshi, L. M., Crowther, D. C., & Dobson, C. M. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.02.011 · Cited by 175
Mechanistic insights and identification of two novel factors in the C. elegans NMD pathway
Longman, D., Plasterk, R. H. A., Johnstone, I. L., & Cáceres, J. F. (2007) · Genes & Development · doi:10.1101/gad.417707 · Cited by 168
“2003), polyglutamine aggregation (Nollen et al. 2004), and longevity (Hamilton et al.”
Self-citationChaperone networks: Tipping the balance in protein folding diseases
Voisine, C., Pedersen, J. S., & Morimoto, R. I. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.007 · Cited by 164
“Bacterial deprivation, i.e. the complete removal of bacteria, the food source for C. elegans, after adulthood results in long-lived animals and suppression of the toxicity of both Aβ and Q35 in an HSF-1 dependent manner (Steinkraus et al., 2008).”
InfluentialSelf-citationSelenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington’s Disease
Cong, W., Bai, R., Li, Y.-F., Wang, L., & Chen, C. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12319 · Cited by 162
Caenorhabditis elegans as a model system for human diseases
Markaki, M., & Tavernarakis, N. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.12.011 · Cited by 177
“A genome-wide RNAi screen using this polyQexpansion model has revealed 186 genes involved in RNA metabolism, protein synthesis, protein folding and protein degradation that induce early onset polyglutamine aggregation when downregulated [45].”
Modeling neurodegeneration in Caenorhabditis elegans
Caldwell, K. A., Willicott, C. W., & Caldwell, G. A. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.046110 · Cited by 178
Zhang, S., Binari, R., Zhou, R., & Perrimon, N. (2010) · Genetics · doi:10.1534/genetics.109.112516 · Cited by 160
“A total of 186 suppressors were isolated from a genomewide RNAi screen for genes regulating polyQ aggregation in C. elegans, and knockdown of these genes by dsRNA promotes aggregates formation in muscles expressed a threshold-length polyQ protein (Q35-YFP) (Nollen et al. 2004).”
InfluentialThe role of molecular chaperones in human misfolding diseases
Broadley, S. A., & Hartl, F. U. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.04.029 · Cited by 152
“elegans identified six of eight TRiC subunits, initially implicating TRiC as an in vivo modulator of polyQ aggregation [92].”
Caenorhabditis elegans: A versatile platform for drug discovery
Artal‐Sanz, M., de Jong, L., & Tavernarakis, N. (2006) · Biotechnology Journal · doi:10.1002/biot.200600176 · Cited by 153
“Others, such as the Huntington’s disease model, have been used in the academic world in genome-wide RNAi screens to identify regulators of polyglutamine aggregation [56].”
UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration
Groen, E. J. N., & Gillingwater, T. H. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.08.003 · Cited by 157
“elegans [59].”
Global Functional Analyses of Cellular Responses to Pore-Forming Toxins
Kao, C., Los, F. C. O., Huffman, D. L., Wachi, S., Kloft, N., Husmann, M., Karabrahimi, V., Schwartz, J. L., Bellier, A., Ha, C., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001314 · Cited by 180
“elegans for hypertonic stress sensitivity [27], osmo-regulation [28], life-span regulation [29,30], fat content regulation [31], protein aggregation regulation [32] and irradiation sensitivity [33] (no other screens involving a challenge related to bacterial pathogenesis have been published to our knowledge) (Figure 1…”
Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans
Voisine, C., Varma, H., Walker, N., Bates, E. A., Stockwell, B. R., & Hart, A. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000504 · Cited by 154
“Furthermore, HSF1 RNAi enhances polyQ aggregation [26] raising the possibility that HSF1 or other stress activated pathways may function as molecular targets of these compounds.”
Li, X., Matilainen, O., Jin, C., Glover-Cutter, K. M., Holmberg, C. I., & Blackwell, T. K. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002119 · Cited by 152
“premature aggregation of transgenic proteins, suggesting a possible downregulation of proteasome activity [42].”
Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans
Kraemer, B. C., Burgess, J. K., Chen, J. H., Thomas, J. H., & Schellenberg, G. D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl067 · Cited by 150
The end of “naïve reductionism”: rise of systems biology or renaissance of physiology?
Strange, K. B. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00598.2004 · Cited by 167
DNAJ Proteins in neurodegeneration: essential and protective factors
Zarouchlioti, C., Parfitt, D. A., Li, W., Gittings, L. M., & Cheetham, M. E. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0534 · Cited by 149
“elegans expressing polyQ proteins identified DNAJ as a suppressor of polyQ aggregation [134].”
Grantham, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00172 · Cited by 136
“In this screen, six CCT subunits, Hsp70 and DnaJ were identified within the “protein folding” functional category of such genes and the authors comment that the range of chaperone proteins identified was somewhat limited (Nollen et al., 2004).”
New genes that extend Caenorhabditis elegans ’ lifespan in response to reproductive signals
McCormick, M., Chen, K., Ramaswamy, P., & Kenyon, C. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00768.x · Cited by 130
“The Ceratitis capitata ortholog has been shown to have ribonuclease activity in vitro (Rampias et al., 2003, and RNAi knockdown of phi-62 has been shown to accelerate protein aggregation in a worm model of polyglutamine-aggregation disease (Nollen et al., 2004).”
Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity
van Ham, T. J., Holmberg, M. A., van der Goot, A. T., Teuling, E., Garcia-Arencibia, M., Kim, H.-E., Du, D., Thijssen, K. L., Wiersma, M., Burggraaff, R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.020 · Cited by 133
“These screens have revealed that a complex network of processes is involved in maintaining protein homeostasis (Nollen et al., 2004; van Ham et al., 2008).”
InfluentialSelf-citationLehner, B., Tischler, J., & Fraser, A. G. (2006) · Nature Protocols · doi:10.1038/nprot.2006.245 · Cited by 132
Identification of a Tissue-Selective Heat Shock Response Regulatory Network
Guisbert, E., Czyż, D. M., Richter, K., McMullen, P. D., & Morimoto, R. I. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003466 · Cited by 134
“elegans that most, if not all, proteasomal subunits are expressed in muscle and that RNAi knockdown of proteasomal subunits yields muscle specific phenotypes such as stabilization of a ubiquitin-GFP reporter in the muscle and early onset aggregation of a polyQ disease model expressed only in the muscle [28,51].”
Self-citationMondal, S., Hegarty, E., Martin, C., Gökçe, S. K., Ghorashian, N., & Ben‐Yakar, A. (2016) · Nature Communications · doi:10.1038/ncomms13023 · Cited by 120
A Genetic Screening Strategy Identifies Novel Regulators of the Proteostasis Network
Silva, M. C., Fox, S., Beam, M., Thakkar, H., Amaral, M. D., & Morimoto, R. I. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002438 · Cited by 119
“This approach was designed to complement our previous efforts to identify enhancers of misfolding by screening for genes that when down-regulated caused the premature appearance of protein aggregates [35].”
InfluentialSelf-citationQuality Control Against Misfolded Proteins in the Cytosol: A Network for Cell Survival
Kubota, H. (2009) · Journal of Biochemistry · doi:10.1093/jb/mvp139 · Cited by 120
Novel therapeutic strategies for the treatment of protein-misfolding diseases
Rochet, J.-C. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000385 · Cited by 118
Mohri-Shiomi, A., & Garsin, D. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707956200 · Cited by 118
Functional ecological genomics to demonstrate general and specific responses to abiotic stress
Roelofs, D., Aarts, M. G. M., Schat, H., & van Straalen, N. M. (2007) · Functional Ecology · doi:10.1111/j.1365-2435.2007.01312.x · Cited by 131
What Can We Learn About Human Disease from the Nematode C. elegans?
Apfeld, J., & Alper, S. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_4 · Cited by 136
“[143] used a genomic RNAi screen to identify 186 genes whose inhibition led C.”
Gidalevitz, T., Kikis, E. A., & Morimoto, R. I. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.11.001 · Cited by 107
“elegans also regulate the protection from osmotic stress-induced protein damage [27 ,29].”
Self-citationModeling human neurodegenerative diseases in transgenic systems
Sosa, M. A. G., Gasperi, R. D., & Elder, G. A. (2011) · Human Genetics · doi:10.1007/s00439-011-1119-1 · Cited by 125
“…of large set of genes involved in protein folding or degradation that increase polyQ aggregation when their expression is knocked down (Nollen et al. 2004) Fruit Fly Drosophila melanogaster AD gmr-GAL4/UAS-driven triple transgenic Xies expressing human wild-type APP, human BACE and…”
Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases
Tittelmeier, J., Nachman, E., & Nussbaum-Krammer, C. I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.581374 · Cited by 118
Drug discovery: Insights from the invertebrate Caenorhabditis elegans
Giunti, S., Andersen, N., Rayes, D., & Rosa, M. J. D. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.721 · Cited by 123
Haenig, C., Atias, N., Taylor, A. K., Mazza, A., Schaefer, M. H., Russ, J., Riechers, S., Jain, S., Coughlin, M., Fontaine, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108050 · Cited by 118
“In addition, the knockdown of the hsp-1 gene, encoding the molecular chaperone Hsc70 (Nollen et al., 2004), was assessed as a”
Proteotoxicity and Cardiac Dysfunction
McLendon, P. M., & Robbins, J. (2015) · Circulation Research · doi:10.1161/circresaha.116.305372 · Cited by 111
A FRET Sensor for Non‐Invasive Imaging of Amyloid Formation in Vivo
Kaminski Schierle, G. S., Bertoncini, C. W., Chan, F. T. S., van der Goot, A. T., Schwedler, S., Skepper, J., Schlachter, S., van Ham, T., Esposito, A., Kumita, J. R., et al. (2011) · ChemPhysChem · doi:10.1002/cphc.201000996 · Cited by 111
Self-citationPapaioannou, E., Wahjudi, M., Nadal-Jimenez, P., Koch, G., Setroikromo, R., & Quax, W. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00380-09 · Cited by 104
Bett, J. S., Goellner, G. M., Woodman, B., Pratt, G., Rechsteiner, M., & Bates, G. P. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi423 · Cited by 108
Garcia, S. M., Casanueva, M. O., Silva, M. C., Amaral, M. D., & Morimoto, R. I. (2007) · Genes & Development · doi:10.1101/gad.1575307 · Cited by 105
“2006), and to establish the critical roles of the age-1/daf-2 insulin-like signaling (ILS) signaling pathways and the heat shock response as potent modulators of polyQ aggregation and toxicity and as lifespan regulators (Morley et al. 2002; Hsu et al. 2003; Nollen et al. 2004).”
InfluentialSelf-citationWacker, J. L., Huang, S.-Y., Steele, A. D., Aron, R., Lotz, G. P., Nguyen, Q., Giorgini, F., Roberson, E. D., Lindquist, S., Masliah, E., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2250-09.2009 · Cited by 103
“…yeast-, worm- and fly-based models of polyQ aggregation and disease (Warrick et al., 1998; Chai et al., 1999; Warrick et al., 1999; Jana et al., 2000; Krobitsch and Lindquist, 2000; Muchowski et al., 2000; Kobayashi and Sobue, 2001; Zhou et al., 2001; Gunawardena et al., 2003; Nollen et al., 2004).”
Zhang, H., Pan, N., Xiong, S., Zou, S., Li, H., Xiao, L., Cao, Z., Tunnacliffe, A., & Huang, Z. (2011) · Biochemical Journal · doi:10.1042/bj20110621 · Cited by 108
Vázquez‐Manrique, R. P., González‐Cabo, P., Ros, S., Aziz, H., Baylis, H. A., & Palau, F. (2006) · The FASEB Journal · doi:10.1096/fj.05-4212fje · Cited by 98
Knight, A. L., Yan, X., Hamamichi, S., Ajjuri, R. R., Mazzulli, J. R., Zhang, M. W., Daigle, J. G., Zhang, S., Borom, A. R., Roberts, L. R., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.017 · Cited by 102
“A previous study identified genetic modifiers of polyQ aggregation (Nollen et al., 2004), but none of those reported were identified in the daf-2 background.”
Modeling Polyglutamine Pathogenesis in C. elegans
Brignull, H. R., Morley, J. F., Garcia, S. M. D. A., & Morimoto, R. I. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)12016-9 · Cited by 115
Self-citationHans, F., Fiesel, F. C., Strong, J. C., Jäckel, S., Rasse, T. M., Geisler, S., Springer, W., Schulz, J. B., Voigt, A., & Kahle, P. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561704 · Cited by 94
“1) enhanced the formation of polyQ protein aggregates (52).”
Molecular Aspects of the Stress Response: Chaperones, Membranes and Networks
Csermely, P., & VÃgh, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-39975-1 · Cited by 104
Tailoring of Proteostasis Networks with Heat Shock Factors
Joutsen, J., & Sistonen, L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034066 · Cited by 106
“One of the first evidences for HSF1 acting as a suppressor of aggregation was provided by a genome-wide RNAi screen in polyQ-expressing C. elegans, which identified CeHSF1 as a factor required to suppress age-related protein aggregation (Nollen et al. 2004).”
Neurodegenerative disorders: Insights from the nematode Caenorhabditis elegans
Dimitriadi, M., & Hart, A. C. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.012 · Cited by 117
Yun, C., Stanhill, A., Yang, Y., Zhang, Y., Haynes, C. M., Xu, C.-F., Neubert, T. A., Mor, A., Philips, M. R., & Ron, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707025105 · Cited by 98
“Polyglutamine reporter animals were grown as described (16).”
Cellular Strategies for Regulating Functional and Nonfunctional Protein Aggregation
Gsponer, J., & Babu, M. M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.036 · Cited by 92
“To test this hypothesis, we investigated published screens in yeast (Willingham et al., 2003) and C. elegans (Nollen et al., 2004) that systematically identified genetic backgrounds in which the phenotype due to the expression of an aggregation-prone protein is enhanced.”
Hesp, K., Smant, G., & Kammenga, J. E. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.09.006 · Cited by 109
Compensatory regulation among ER chaperones in C. elegans
Kapulkin, V., Hiester, B. G., & Link, C. D. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.062 · Cited by 91
DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis
Thiruvalluvan, A., de Mattos, E. P., Brunsting, J. F., Bakels, R., Serlidaki, D., Barazzuol, L., Conforti, P., Fatima, A., Koyuncu, S., Cattaneo, E. F., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.02.022 · Cited by 94
Amyloid in neurodegenerative diseases: Friend or foe?
Wolfe, K. J., & Cyr, D. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.03.011 · Cited by 103
“elegans [62], yeast [63], and cell culture [64].”
Honda, Y., Higashibata, A., Matsunaga, Y., Yonezawa, Y., Kawano, T., Higashitani, A., Kuriyama, K., Shimazu, T., Tanaka, M., Szewczyk, N. J., et al. (2012) · Scientific Reports · doi:10.1038/srep00487 · Cited by 87
Noormohammadi, A., Khodakarami, A., Gutiérrez-García, R., Lee, H. J., Koyuncu, S., König, T., Schindler, C., Sáez, I., Fatima, A., Dieterich, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13649 · Cited by 86
Metadata
- Authors
- Nollen, E. A. A., Garcia, S. M., van Haaften, G., Kim, S., Chavez, A., Morimoto, R. I., & Plasterk, R. H. A.
- Affiliations
- Northwestern University (US)
- Division of Functional Genomics, Hubrecht Laboratories/Netherlands Institute for Developmental Biology, 3584 CT Utrecht, The Netherlands; and Department of Biochemistry, Molecular Biology, and Cell Biology, Rice Institute for Biomedical Research, Northwestern University, Evanston, IL 60208
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-04-14
- Volume
- 101
- Issue
- 17
- Pages
- 6403-6408
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC404057
- OpenAlex
- W1511237419
- Cited by
- 416
- References
- 35
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 20 · 2023: 7 · 2022: 18 · 2021: 18 · 2020: 15 · 2019: 9 · 2018: 11 · 2017: 15 · 2016: 16 · 2015: 14 · 2014: 22 · 2013: 20 · 2012: 26
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- polyglutamine aggregation, protein misfolding, proteostasis, polyglutamine diseases, RNAi screen, Caenorhabditis elegans, RNA metabolism, protein synthesis, protein folding, protein degradation, protein trafficking, neurodegenerative diseases
- MeSH terms
- Animals, Microscopy, Electron, Peptides, Blotting, Western, Genome, Caenorhabditis elegans, RNA Interference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.